Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 1, 2002, Pages 101-108

  Özyar, Enis ^a   Yildz, Ferah ^a   Akyol, Fadil H ^a   Atahan, I Lale ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Brachytherapy; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

CHEMOTHERAPY; DISEASES; PATIENT TREATMENT; TUMORS;

SURVIVAL RATES;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; CISPLATIN; IRIDIUM 192;

ADOLESCENT; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER STAGING; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NEUROPATHY; NOSE CAVITY; NOSE CONGESTION; NOSE OBSTRUCTION; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RADIATION APPLICATOR; RADIATION DOSE; RECURRENCE RISK; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036140108     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01818-1     Document Type: Article

References (27)

1. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
2. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx
3. Comparison of AJCC and 1997 classifications for nasopharyngeal carcinoma
4. Management of local residual primary lesion of nasopharyngeal carcinoma; II. Results of prospective randomized trial on booster dose.
5. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx techniques and results
6. Radiation therapy of nasopharyngeal carcinoma
7. Management of local residual primary lesion of nasopharyngeal carcinoma; II. Results of prospective randomized trial on booster dose.
8. Three-dimensional photon treatment planning for carcinoma of the nasopharynx
9. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma; The University of California-San Francisco experience
10. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma; Impact on local control
11. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy
12. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial
13. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma; The existence of a dose-tumour-control relationship above conventional tumoricidal dose
14. Permanent Iodine-125 (I-125) boost implants after external radiation therapy in nasopharyngeal carcinoma
15. Nonparametric estimation from incomplete observations
16. Regression models and life tables
17. The role of brachytherapy in early-stage nasopharyngeal carcinoma
18. Radiation management of advanced nasopharyngeal cancer
19. Radiation therapy of nasopharyngeal carcinoma; Prognostic factors based on a 10-year follow-up of 1302 patients
20. A radium applicator for treating carcinoma of the nasopharynx
21. Improved survival of patients with nasopharyngeal squamous cell carcinoma
22. Combined teletherapy and intracavitary brachytherapy boost for the treatment of nasopharyngeal carcinoma
23. Comment on; Caution on the use of altered fractionation for nasopharyngeal carcinoma
24. Implementation of a model for estimating tumor control probability for an inhomogenously irradiated tumor
25. Results of prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
26. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer; Phase III randomized intergroup study 0099